Ana Ricobaraza
- Biological Psychiatry top 5%
-
- Neuroscience and Neuropharmacology Research 10
- Pharmacology top 2%
- Cannabis and Cannabinoid Research 5
- Neurology top 5%
- Physiology top 5%
- Alzheimer's disease research and treatments 7
-
- Epilepsy research and treatment 4
-
- Receptor Mechanisms and Signaling 4
- CRISPR and Genetic Engineering 3
-
- Neurogenesis and neuroplasticity mechanisms 4
-
- Virus-based gene therapy research 3
- Co-authors
- Mar Cuadrado‐TejedorAna Garcı́a-OstaAlberto Pérez‐MediavillaDiana FrechillaRafael FrancoJoaquín del Río FernándezElena PuertaSònia Marco
- Journals
- Journal of Clinical Investigation (1 paper)Nature Communications (1 paper)PLoS ONE (1 paper)
- Partner nations
- SpainFranceUnited States
In The Last Decade
Ana Ricobaraza
35 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 103
- Biological Psychiatry 140
- Cellular and Molecular Neuroscience 588
- Pharmacology 498
- Neurology 217
- Physiology 618
Countries citing papers authored by Ana Ricobaraza
This map shows the geographic impact of Ana Ricobaraza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Ricobaraza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Ricobaraza more than expected).
Fields of papers citing papers by Ana Ricobaraza
This network shows the impact of papers produced by Ana Ricobaraza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Ricobaraza. The network helps show where Ana Ricobaraza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana Ricobaraza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | 2023 | 6 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 11 | |
| 5 | 2021 | 28 | |
| 6 | 2019 | 53 | |
| 7 | 2019 | 46 | |
| 8 | 2016 | 3 | |
| 9 | 2016 | 9 | |
| 10 | 2015 | 19 | |
| 11 | 2014 | 66 | |
| 12 | 2014 | 103 | |
| 13 | 2013 | 11 | |
| 14 | 2013 | 53 | |
| 15 | 2013 | 8 | |
| 16 | 2012 | 147 | |
| 17 | 2011 | 29 | |
| 18 | 2011 | 38 | |
| 19 | 2010 | 202 | |
| 20 | 2009 | 333 |
About Ana Ricobaraza
Ana Ricobaraza is a scholar working on Biological Psychiatry, Developmental Neuroscience and Cellular and Molecular Neuroscience, having authored 35 papers that have together received 2.2k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (10 papers), Alzheimer's disease research and treatments (7 papers), Cannabis and Cannabinoid Research (5 papers), Epilepsy research and treatment (4 papers), Receptor Mechanisms and Signaling (4 papers), Neurogenesis and neuroplasticity mechanisms (4 papers), Virus-based gene therapy research (3 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Biological Psychiatry (140 citations), Cellular and Molecular Neuroscience (588 citations) and Pharmacology (498 citations). Ana Ricobaraza has collaborated with scholars based in Spain, France and United States. Frequent co-authors include Mar Cuadrado‐Tejedor, Ana Garcı́a-Osta, Alberto Pérez‐Mediavilla, Diana Frechilla, Rafael Franco, Joaquín del Río Fernández, Elena Puerta, Sònia Marco, Isabel Pérez‐Otaño and Zsolt Lenkei. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.